Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease

被引:24
作者
Chan, Hugh [1 ]
Paur, Helen [1 ]
Vernon, Anthony C. [1 ,2 ]
Zabarsky, Virginia [1 ]
Datla, Krishna P. [1 ]
Croucher, Martin J. [1 ]
Dexter, David T. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Parkinsons Dis Res Grp, Fac Med, Hammersmith Hosp, London W12 0NN, England
[2] Kings Coll London, Ctr Cellular Basis Behav, Dept Neurosci, Inst Psychiat,James Black Ctr, London SE5 9NU, England
基金
英国医学研究理事会;
关键词
METABOTROPIC GLUTAMATE RECEPTORS; GROUP-II; INDUCED NEUROTOXICITY; D2(HIGH) RECEPTORS; AGONIST LY379268; 6-HYDROXYDOPAMINE; MGLU2; DEGENERATION; STIMULATION; PHENCYCLIDINE;
D O I
10.4061/2010/190450
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Clinical trials have demonstrated positive proof of efficacy of dual metabotropic glutamate receptor 2/3 (mGluR2/3) agonists in both anxiety and schizophrenia. Importantly, evidence suggests that these drugs may also be neuroprotective against glutamate excitotoxicity, implicated in the pathogenesis of Parkinson's disease (PD). However, whether this neuroprotection also translates into functional recovery is unclear. In the current study, we examined the neuroprotective efficacy of the dual mGluR2/3 agonist, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC), and whether this is accompanied by behavioral recovery in a rodent 6-hydroxydopamine (6-OHDA) model of PD. We now report that delayed post lesion treatment with 2R,4R-APDC (10 nmol), results in robust neuroprotection of the nigrostriatal system, which translated into functional recovery as measured by improved forelimb use asymmetry and reduced (+)-amphetamine-induced rotation compared to vehicle treated animals. Interestingly, these beneficial effects were associated with a decrease in microglial markers in the SNc, which may suggest an antiinflammatory action of this drug.
引用
收藏
页数:12
相关论文
共 47 条
[11]   The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection [J].
Corti, Corrado ;
Battaglia, Giuseppe ;
Molinaro, Gemma ;
Riozzi, Barbara ;
Pittaluga, Anna ;
Corsi, Mauro ;
Mugnaini, Manolo ;
Nicoletti, Ferdinando ;
Bruno, Valeria .
JOURNAL OF NEUROSCIENCE, 2007, 27 (31) :8297-8308
[12]   RETRACTED: Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways (Retracted article. See vol. 129, pg. 1035, 2014) [J].
D'Onofrio, M ;
Cuomo, L ;
Battaglia, G ;
Ngomba, RT ;
Storto, M ;
Kingston, AE ;
Orzi, F ;
De Blasi, A ;
Di Iorio, P ;
Nicoletti, F ;
Bruno, V .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (03) :435-445
[13]   The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat [J].
Dawson, L ;
Chadha, A ;
Megalou, M ;
Duty, S .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) :541-546
[14]   Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder [J].
Dunayevich, Eduardo ;
Erickson, Janelle ;
Levine, Louise ;
Landbloom, Ronald ;
Schoepp, Darryle D. ;
Tollefson, Gary D. .
NEUROPSYCHOPHARMACOLOGY, 2008, 33 (07) :1603-1610
[15]   A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity [J].
Galici, R ;
Echemendia, NG ;
Rodriguez, AL ;
Conn, PJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :1181-1187
[16]   Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice [J].
Galici, Ruggero ;
Jones, Carrie K. ;
Hemstapat, Kamondanai ;
Nong, Yi ;
Echemendia, Nicholas G. ;
Williams, Lilly C. ;
de Paulis, Tomas ;
Conn, P. Jeffrey .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (01) :173-185
[17]   Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0] hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell [J].
Greenslade, RG ;
Mitchell, SN .
NEUROPHARMACOLOGY, 2004, 47 (01) :1-8
[18]   Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration [J].
Iravani, MM ;
Kashefi, K ;
Mander, P ;
Rose, S ;
Jenner, P .
NEUROSCIENCE, 2002, 110 (01) :49-58
[19]   Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord [J].
Jane, DE ;
Thomas, NK ;
Tse, HW ;
Watkins, JC .
NEUROPHARMACOLOGY, 1996, 35 (08) :1029-1035
[20]   The pathogenesis of cell death in Parkinson's disease [J].
Jenner, Peter ;
Olanow, C. Warren .
NEUROLOGY, 2006, 66 (10) :S24-S36